Leith States is the chief medical officer in HHS’ Office of the Assistant Secretary for Health, where he has a broad portfolio that includes telehealth, long Covid and InnovationX, the department’s self-described bid to solve “wicked problems.” He joined the Department of Health and Human Services in 2018 from the Navy Medical Corps. Ben caught up with States to discuss audio-only telehealth, the future of the Office of Long Covid Research and Practice, InnovationX and more. This interview has been edited for length and clarity. Congress has extended telehealth coverage in Medicare, and lawmakers are looking to make it permanent. But they are skeptical about covering audio-only visits. What do you think? Telehealth is a really helpful disrupter. It’s going to fundamentally change the way care delivery is provided. But it’s not a sledgehammer. It has a targeted space. There are a variety of indications where you may have true value with video — the ability to pick up body language and informal cues. The issue with trying to push through audio-only is that, in certain instances, you could do more harm than good if you are using that checkpoint on equal footing with an in-person or video teleconference. If you have someone with a history of substance use, serious mental illness or suicidality, these are some things you might pick up on as a clinician by seeing the person in person or on video. What are InnovationX’s biggest challenges? The unfortunate part for InnovationX is that while we have a density of innovators, technologists and data scientists, the funding can be a mismatch with our charge: looking for ways to complement ongoing or nascent efforts across the department. PandemicX was part of InnovationX that aimed to tackle issues tied to Covid. Any lessons learned? Will there be something similar in the future? That’s the issue with unfunded mandates. A lot of times, they are based in really great ideas, but we haven’t gotten to the point where there’s been the capacity to even capitalize on or share anything that’s come from those experiences. We’re hoping we can come back to it. HHS hasn’t yet stood up the Office of Long Covid Research and Practice it announced last year, prompting questions from Democrats in Congress. What’s next? We are in the process of not just the formal standup, but also the meaningful and pragmatic operationalization. We’re building out the personnel, staffing and capacity to have some identifiable workstreams. We’re ready, hopefully, to have a director named in the near future. Before the end of the fiscal year, we fully anticipate a true announcement that it’s launched.
|